Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10568575.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three patients with diffuse large B-cell type of post-transplant lymphoproliferative disease after lung transplantation were treated with rituximab, an anti-CD20 monoclonal antibody. Treatment resulted in two complete remissions and one non-response.
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Lung Neoplasms
- Lung Transplantation
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Postoperative Complications